Patent expiry and biosimilars: difference between revisions
Diff·revision 14 → 15·16:41, 8 Jul 2025
Difference between revision 14 and revision 15 of Patent expiry and biosimilars. This revision changed no lines of source — the edit was a null or whitespace change.
| Revision 14 — 12:41, 20 Jun 2025 Chromatokid (talk) clarify the difference between a marketing authorisation and a registration 3,580 bytes ±0 | Revision 15 — 16:41, 8 Jul 2025 RedirectRini (talk) fix the anchor on an internal link 3,580 bytes ±0 | ||
|---|---|---|---|
| — | No change to the page source. | — |